Genprex Inc

Research Genprex Inc (GNPX) on Bullrun: market cap USD 5.35M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGNPX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.35M
• Financial periodFY2025
• Net income-USD 16.23M

Valuation Snapshot

latest market cap is USD 5.35M.

About Genprex Inc

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form.

Frequently asked questions

What is Genprex Inc's market cap?

Genprex Inc's market capitalization is USD 5.35M.

What does Genprex Inc do?

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes.